Analyst	Recommendation	Action	Price target	Projected	Date
Matthew Caufield H.C. Wainwright	Buy	Maintained	$6.00	+404.2%	08/04/2026
Michael Okunewitch Maxim Group	Hold	Downgraded	-	-	05/04/2026
Jason Kolbert D. Boral Capital	Hold	Downgraded	-	-	03/26/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	2.79M	797.00K	2.95M	1.66M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.25M	1.79M	2.12M	2.38M
Operating expense	5.04M	2.59M	5.07M	4.03M
Total operating expenses	5.04M	2.59M	5.07M	4.03M
Operating income	-5.04M	-2.59M	-5.07M	-4.03M
Other non operating income	-813.00K	-475.00K	54.00K	-92.00K
EBT including unusual items	-5.78M	-3.24M	-5.00M	-4.12M
EBT excluding unusual items	-5.78M	-3.24M	-5.00M	-4.12M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-5.78M	-3.24M	-5.00M	-4.12M
Net profit margin	-	-	-	-
Earnings per share	-2.60	-0.60	-1.33	-0.66
Interest and investment income	73.00K	25.00K	20.00K	15.00K
Interest expense	-	-204.00K	-4.00K	-7.00K
Net interest expenses	73.00K	-179.00K	16.00K	8.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-4.97M	-2.52M	-5.00M	-3.97M
Gain or loss from assets sale	-	-	-	-

Finance

Research